|
π
|
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
18 auth.
Kento Imajo,
Takaomi Kessoku,
Y. Honda,
Wataru Tomeno,
Yuji Ogawa,
H. Mawatari,
K. Fujita,
M. Yoneda,
M. Taguri,
H. Hyogo,
...
Y. Sumida,
M. Ono,
Yuichiro Eguchi,
Tomio Inoue,
T. Yamanaka,
K. Wada,
S. Saito,
A. Nakajima
|
9 |
2016 |
9
π
|
|
π
|
Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.
18 auth.
Kento Imajo,
K. Fujita,
M. Yoneda,
Y. Nozaki,
Yuji Ogawa,
Yoshiyasu Shinohara,
S. Kato,
H. Mawatari,
W. Shibata,
H. Kitani,
...
K. Ikejima,
H. Kirikoshi,
N. Nakajima,
S. Saito,
S. Maeyama,
Sumio Watanabe,
K. Wada,
A. Nakajima
|
8 |
2012 |
8
π
|
|
π
|
Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease
21 auth.
M. Yoneda,
Shuhei Naka,
K. Nakano,
K. Wada,
Hiroki Endo,
H. Mawatari,
Kento Imajo,
R. Nomura,
K. Hokamura,
M. Ono,
...
S. Murata,
I. Tohnai,
Y. Sumida,
T. Shima,
M. Kuboniwa,
K. Umemura,
Y. Kamisaki,
A. Amano,
T. Okanoue,
T. Ooshima,
A. Nakajima
|
7 |
2012 |
7
π
|
|
π
|
Dysfunctional veryβlowβdensity lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
14 auth.
K. Fujita,
Y. Nozaki,
K. Wada,
M. Yoneda,
Yoko Fujimoto,
M. Fujitake,
Hiroki Endo,
Hirokazu Takahashi,
M. Inamori,
N. Kobayashi,
...
H. Kirikoshi,
K. Kubota,
S. Saito,
A. Nakajima
|
7 |
2009 |
7
π
|
|
π
|
Endogenous PPARΞ³ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
12 auth.
A. Nakajima,
K. Wada,
H. Miki,
N. Kubota,
N. Nakajima,
Y. Terauchi,
...
S. Ohnishi,
L. Saubermann,
T. Kadowaki,
R. Blumberg,
R. Nagai,
N. Matsuhashi
|
7 |
2001 |
7
π
|
|
π
|
Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
11 auth.
Emi Osawa,
A. Nakajima,
K. Wada,
S. Ishimine,
N. Fujisawa,
T. Kawamori,
...
N. Matsuhashi,
T. Kadowaki,
M. Ochiai,
H. Sekihara,
H. Nakagama
|
7 |
2003 |
7
π
|
|
π
|
Protective mucosal immunity mediated by epithelial CD1d and IL-10
22 auth.
T. Olszak,
J. Neves,
C. Dowds,
K. Baker,
J. Glickman,
N. Davidson,
Chyuan-Sheng Lin,
C. Jobin,
S. Brand,
K. Sotlar,
...
K. Wada,
K. Katayama,
A. Nakajima,
H. Mizuguchi,
K. Kawasaki,
K. Nagata,
Werner MΓΌller,
S. Snapper,
S. Schreiber,
A. Kaser,
S. Zeissig,
R. Blumberg
|
7 |
2014 |
7
π
|
|
π
|
Metformin suppresses intestinal polyp growth in ApcMin/+ mice
11 auth.
A. Tomimoto,
Hiroki Endo,
Michiko Sugiyama,
T. Fujisawa,
K. Hosono,
Hirokazu Takahashi,
...
N. Nakajima,
Y. Nagashima,
K. Wada,
H. Nakagama,
A. Nakajima
|
7 |
2008 |
7
π
|
|
π
|
A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model.
11 auth.
K. Katayama,
K. Wada,
A. Nakajima,
H. Mizuguchi,
T. Hayakawa,
S. Nakagawa,
...
T. Kadowaki,
R. Nagai,
Y. Kamisaki,
R. Blumberg,
T. Mayumi
|
7 |
2003 |
7
π
|
|
π
|
Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway.
12 auth.
Michiko Sugiyama,
Hirokazu Takahashi,
K. Hosono,
Hiroki Endo,
S. Kato,
K. Yoneda,
...
Y. Nozaki,
K. Fujita,
M. Yoneda,
K. Wada,
H. Nakagama,
A. Nakajima
|
7 |
2009 |
7
π
|
|
π
|
Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition
15 auth.
Toshio Fujisawa,
Hiroki Endo,
A. Tomimoto,
Michiko Sugiyama,
Hirokazu Takahashi,
S. Saito,
M. Inamori,
Noriko Nakajima,
Masatoshi Watanabe,
N. Kubota,
...
T. Yamauchi,
Takashi Kadowaki,
K. Wada,
Hitoshi Nakagama,
Atsushi Nakajima
|
7 |
2008 |
7
π
|
